Core Viewpoint - The company West B is addressing customer concerns regarding its food production processes and has acknowledged a significant gap between its practices and customer expectations. The company has committed to implementing nine adjustments across its nationwide stores by October 1, 2025, to enhance customer experience and food safety [1][4][8]. Group 1: Customer Concerns and Company Response - West B issued an apology on September 15, acknowledging the confusion and concerns raised by customers regarding its food production methods [1][4]. - The company emphasized its commitment to food safety and compliance with national regulations while actively seeking to improve its production processes [4][5]. - The adjustments planned include transitioning from pre-prepared to freshly made items in stores, such as using non-GMO soybean oil and preparing various dishes on-site [3][5]. Group 2: Impact of Controversy - The controversy began on September 10 when a public figure criticized West B's dishes as pre-prepared, leading to a heated exchange between the company's founder and the critic [8][9]. - Following the criticism, West B experienced a significant drop in daily revenue, with losses estimated at 1 million yuan on September 10 and 11, and further declines of 2 to 3 million yuan on September 12 [9]. - The company had to halt its initiative to allow public kitchen inspections after negative reports surfaced regarding food safety practices [9].

| 单位：万元 | | --- | | 项目 | 2025年上半年 | | | --- | --- | --- | | | 金额 | 比例 | | 大豆分离蛋白 | 25,087.69 | 32.56% | | 非转基因大豆油 | 16,088.05 | 20.88% | | 组织化蛋白 | 13,436.16 | 17.44% | | 大豆浓缩蛋白 | 15,458.36 | 20.06% | | 其他产品 | 6,985.49 | 9.07% | | 合计 | 77,055.75 | 100.00% | 证券代码：603231 证券简称：索宝蛋白 公告编号：2025-022 宁波索宝蛋白科技股份有限公司 2025年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，宁波索宝蛋白科技股份有限公司（以下简称"公 司"）现将 2025 年半年度主要经营数据公告如下： 一、按产品类别分类的主营业务销售情况 单位： ...

Core Viewpoint - The Ironling Market Supervision Administration conducted food safety inspections, revealing that out of 12 batches tested, 11 were compliant while 1 was deemed non-compliant, leading to further investigation and handling procedures [2]. Summary by Category Food Safety Inspection Results - A total of 12 batches were tested, covering 7 major categories including grain products, starch and starch products, meat products, dairy products, edible oils, vegetable products, and catering foods [2]. - Out of the 12 batches, 11 were found to be compliant with food safety standards, while 1 batch was identified as non-compliant [2]. Non-Compliant Sample Details - The non-compliant sample was from a catering business, specifically a meat dish, which contained anionic synthetic detergent (sodium dodecylbenzenesulfonate) at a level of 0.0626 mg/100 cm², exceeding the allowable limit of "not detectable" [2]. Compliant Sample Highlights - Several compliant products were highlighted, including: - Non-GMO soybean oil from Jiu San Food Co., Ltd. (900 mL) [2] - Five-spice chicken from Dezhou Huaye Food Co., Ltd. (500 g) [2] - Various dairy products from Liaoning Yili Dairy Co., Ltd. and Tianjin Haihe Dairy Co., Ltd. [2] - Wheat flour from Inner Mongolia Hengfeng Group [2].

Core Insights - The edible oil industry in China is characterized by a complex supply chain that includes agricultural production, processing, packaging, and sales channels [1] - Major listed companies in the industry include Jinlongyu (300999.SZ), Shenliang Holdings (000019.SZ), and others, with Jinlongyu leading in revenue and market share [1][8] Industry Overview - The edible oil supply chain consists of upstream agricultural production, midstream processing companies, and downstream sales channels [1] - The industry has seen a decline in revenue across most listed companies in 2024, indicating increased competition and market pressure [8][15] Company Performance - Jinlongyu reported a revenue of 238.87 billion yuan in 2024, maintaining a leading position despite a decline of 10.37% in its feed raw materials and oil technology business [8][15] - Shenliang Holdings and Jinlongyu both experienced growth in net profit in Q1 2025, with increases of 42.97% and 11.24% respectively [9][10] - Other companies like Su Kuan Agricultural Development and Jingliang Holdings faced significant revenue declines in 2024 [10] Financial Metrics - As of May 27, 2025, Jinlongyu's total market capitalization reached 165.196 billion yuan, while other companies like Su Kuan Agricultural Development also exceeded 10 billion yuan [9][10] - The profit margins varied significantly among companies, with West King Food achieving a gross margin of 22.86%, while Jinlongyu and Shenliang Holdings reported margins below 3% [18] Business Strategies - Jinlongyu plans to expand into the health industry and enhance its product offerings through technological innovation [22][24] - Jingliang Holdings aims to strengthen its supply chain and marketing strategies to improve its trade business [22][24] - West King Food focuses on brand building and cost control to enhance competitiveness [22][24] Market Dynamics - The overseas revenue distribution among companies is uneven, with West King Food and others relying heavily on international markets, although some have seen declines in overseas sales [20][21] - The edible oil industry is facing challenges due to increased competition and market pressures, leading to varied performance among listed companies [15][18]

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-014 宁波索宝蛋白科技股份有限公司 2025年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 项目 | 2025年第一季度 | | | --- | --- | --- | | | 金额 | 比例 | | 境内 | 23,532.92 | 60.24% | | 境外 | 15,532.06 | 39.76% | | 合计 | 39,064.98 | 100.00% | 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，宁波索宝蛋白科技股份有限公司（以下简称"公 司"）现将 2025年第一季度主要经营数据公告如下： 一、按产品类别分类的主营业务销售情况 单位：万元 | 项目 | 2025年第一季度 | | | --- | --- | --- | | | 金额 | 比例 | | 大豆分离蛋白 | 12,475.93 | 31.94% | | 非转基因大豆油 | 8,727.65 | 22. ...

宁波索宝蛋白科技股份有限公司 Solbar Ningbo Protein Technology Co., Ltd. (注册地址:浙江省宁波保税区兴业大道12号) 首次公开发? 在主板上市 招股说明书 (注册稿) 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招 股说明书不具有据以发行股票的法律效力,仅供预先披露之用。投资者应当 以正式公告的招股说明书全文作为作出投资决定的依据。 保荐机构(主承销商) FILE HOST SOOCHOW SECURITIES CO.,LTD (注册地址:苏州工业园区星阳街5号) 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 宁波索宝 ...

宁波索宝蛋白科技股份有限公司 （注册地址：浙江省宁波保税区兴业大道 12 号） 首次公开发行股票并在主板上市 招股说明书 （上会稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招 股说明书不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当 保荐机构（主承销商） 1-1-1 Solbar Ningbo Protein Technology Co., Ltd. 以正式公告的招股说明书全文作为作出投资决定的依据。 1-1-1 宁波索宝蛋白科技股份有限公司 招股说明书（上会稿） 本次发行概况 （注册地址：苏州工业园区星阳街5号） | 股票种类 | 人民币普通股（A 股） | | --- | --- | | 发行股数 | 本次公开发行股票数量不超过 万股，全部为新股发行，不涉 4,786.48 | | | 及股东公开发售股份。 | | 每股面值 | 人民币 1.00 元 | | 每股发行价格 | 人民币【】元 | | 预计发行日期 | 【】年【】月【】日 | | 拟上市的证券交易 所 | 上海证券交易所 | | 发行后总股本 | 不超过 19,145.9105 万股 | | 保荐人、主承销 ...

宁波索宝蛋白科技股份有限公司 Solbar Ningbo Protein Technology Co., Ltd. （注册地址：浙江省宁波保税区兴业大道 12 号） 首次公开发行股票并在主板上市 招股说明书 （申报稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招 股说明书不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当 以正式公告的招股说明书全文作为作出投资决定的依据。 保荐机构（主承销商） （注册地址：苏州工业园区星阳街5号） 1-1-1 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 宁波索宝蛋白科技股份有限公司 招股说明书（申报稿） 本次发行概 ...

宁波索宝蛋白科技股份有限公司 Solbar Ningbo Protein Technology Co., Ltd. （注册地址：浙江省宁波保税区兴业大道 12 号） 首次公开发行股票 招股说明书 （申报稿） 保荐机构（主承销商） （注册地址：苏州工业园区星阳街5号） 宁波索宝蛋白科技股份有限公司 招股说明书（申报稿） 声明：本公司的发行申请尚未得到中国证监会核准。本招股说明书（申报稿） 不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当以正式公告的 招股说明书全文作为作出投资决定的依据。 | 股票种类 | 股） 人民币普通股（A | | --- | --- | | 发行股数 | 本次公开发行股票数量不超过 4,786.48 万股，全部为新股发行，不涉 | | | 及股东公开发售股份。 | | 每股面值 | 人民币 元 1.00 | | 每股发行价格 | 人民币【】元 | | 预计发行日期 | 【】年【】月【】日 | | 拟上市的证券交易 | 上海证券交易所 | | 所 | | | 发行后总股本 | 不超过 万股 19,145.91 | | 本次发行前股东所 持股份的流通限制、 | 参见本招股说明书"重 ...